Quarterly report pursuant to Section 13 or 15(d)

MEZZANINE EQUITY - Narrative (Details)

v3.24.2.u1
MEZZANINE EQUITY - Narrative (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2023
shares
Jun. 30, 2023
shares
Jun. 30, 2024
USD ($)
shareholder
$ / shares
Rate
shares
Dec. 31, 2023
shareholder
shares
Dec. 31, 2021
$ / shares
shares
May 02, 2024
$ / shares
shares
Temporary Equity [Line Items]            
Number of unaffiliated investors | shareholder     3 3    
Warrants to purchase common stock (in shares)     43,089,476     1,000,000
Exercise price of warrants (in dollars per share) | $ / shares     $ 0.67   $ 1.087 $ 0.32
Series B Convertible Preferred Stock            
Temporary Equity [Line Items]            
Share price (in dollars per share) | $ / shares     $ 3.00      
Term of option to convert (in years)     6 years      
Conversion price of preferred stock (in dollars per share) | $ / shares     $ 3.00      
Threshold VWAP, in excess of (in dollars per share) | $ / shares     $ 4.00      
Number of consecutive trading days     20 days      
Convertible preferred stock, outstanding (in shares)     4,908,333 4,908,333    
Number of consecutive trading dates after anniversary     60 days      
VWAP threshold, less than or equal to (in dollars per share) | $ / shares     $ 0.50      
Conversion ratio (in shares)     1      
Value of shares converted | $     $ 14,725      
VWAP threshold, greater than (in dollars per share) | $ / shares     $ 0.50      
Convertible preferred stock, issued (in shares)     4,908,333 4,908,333    
Series C Convertible Preferred Stock            
Temporary Equity [Line Items]            
Number of shares converted (in shares) 784,334 4,276,608   5,060,942    
Convertible preferred stock, outstanding (in shares)     1,155,274 1,155,274    
Conversion ratio (in shares) | Rate     500.00%      
Convertible preferred stock, issued (in shares)     1,155,274 1,155,274    
Series C Convertible Preferred Stock | Hadron Healthcare            
Temporary Equity [Line Items]            
Shares issued (in shares)         6,216,216  
Common stock            
Temporary Equity [Line Items]            
Number of shares converted (in shares)       25,304,710    
Shares issued on conversion of preferred stock (per share) 3,921,670 21,383,040     5  
Common stock | Maximum            
Temporary Equity [Line Items]            
Warrants to purchase common stock (in shares)         15,540,540  
Two Unaffiliated Institutional Shareholders | Series B Convertible Preferred Stock | Exchange Agreement            
Temporary Equity [Line Items]            
Number of shares converted (in shares)     4,908,333 4,908,333